Drug Database
PA

pasireotide (Signifor LAR / pasireotide, LAR / pasireotide LAR)

✓ Approved

Novartis AG · SSTR1 · 小分子

什么是 pasireotide?

pasireotide 是一种小分子,由Novartis AG研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intramuscular (IM) Injection、Subcutaneous Injection。

药物档案

商品名Signifor LAR, pasireotide, LAR, pasireotide LAR
公司Novartis AG
药物类别小分子, 多肽类
分子靶点SSTR1, SSTR2, SSTR3, SSTR5
给药途径Injectable (Others), Intramuscular (IM) Injection, Subcutaneous Injection
状态Approved

作用机制

分子靶点

pasireotide 作用于 4 个分子靶点:

SSTR1somatostatin receptor 1 (SS-1-R, SS1-R)
SSTR2somatostatin receptor 2 (SST2)
SSTR3somatostatin receptor 3 (SST3, SS3R)
SSTR5somatostatin receptor 5 (SST5, SS-5-R)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

pasireotide 针对 11 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
Endocrine disordersAcromegaly✓ Approved
Endocrine disordersPituitary-dependent Cushing's syndrome✓ Approved
Endocrine disordersCarcinoid syndromePhase III
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Colon cancer recurrentPhase III
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Pituitary tumour benignPhase II

注册免费账户还可查看另外 6 个适应症

免费注册查看全部适应症 →

相关研究文献

PubMedTechniques in coloproctology2026-11-17

Loop colostomy offers comparable short-term surgical outcomes with fewer metabolic complications than loop ileostomy after laparoscopic low anterior resection post-total neoadjuvant therapy: developing-country perspective.

Dabous Ali A, Ghanayem Mohammad B MB, Al Matairi Alzahra'a A, Rajab Ibrahim I et al.

Defunctioning stomas are standard in low anterior resection (LAR) posttotal neoadjuvant therapy (TNT) to mitigate anastomotic complications. While loop ileostomy is common, it poses significant metabolic risks. This study investigates whether loop colostomy may reduce renal and electrolyte complications, without compromising surgical or stoma reversal outcomes. We retrospectively analyzed 97 patients with rectal cancer treated at King Hussein Cancer Center (January 2020 to November 2024) who underwent TNT followed by LAR with a defunctioning stoma (ileostomy, n = 57; colostomy, n = 40). Primary outcomes were acute kidney injury (AKI) and hyponatremia. Secondary outcomes included stoma-related and closure-related complications. Data were compared using chi-squared, Mann-Whitney U-test, and Kaplan-Meier analysis. Baseline characteristics were comparable, except for higher baseline creatinine in ileostomy patients (p = 0.002). Ileostomy was associated with more AKI (35.1% versus 2.5%, p < 0.001) and hyponatremia (57.8% versus 20.0%, p < 0.001) with greater stoma output (p < 0.001). Skin excoriation was more frequent with ileostomy (24.5% versus 5.0%, p = 0.011), while colostomy had higher stoma prolapse (22.5% versus 1.7%, p < 0.001). Other postoperative outcomes were similar. However, blood loss during stoma reversal was greater with ileostomy (p < 0.001). Kaplan-Meier analysis showed no difference in time to closure (median 84 versus 85 days, p = 0.491). In multivariate analysis, ileostomy remained associated with AKI and hyponatremia after adjustment for the included covariates. Loop colostomy may represent an alternative to loop ileostomy after LAR following TNT, with fewer metabolic complications and comparable surgical outcomes, despite a higher prolapse risk.

PMID 43040093
阅读全文 →
PubMedAmerican journal of infection control2026-11-16

Impact to Healthcare-Associated Viral Gastroenteritis Infection Rate Using Different Visitation Models in a Pediatric Hospital.

Rusin Kellie K, Saporta-Keating Sara R SR, Pearce Kelly K, Silveira Lori L et al.

Pediatric healthcare-associated viral gastroenteritis infections (HA-VGI) contribute to morbidity, prolonged hospitalization, and outbreaks. Visitor-related transmission is a recognized risk factor; associations between visitation models and HA-VGI incidence remain understudied. HA-VGI rates were compared across four visitation models: (Period 1) seasonal visitation, visitors <13 years restricted December 1-April 30; (Period 2) two legally authorized representatives (LAR) permitted, mandatory masking; (Period 3) masking with an LAR-approved 10-person visitor list, including siblings; (Period 4) identical visitation model without masking (December 2017-June 2025). HA-VGI was defined as gastroenteritis on or after hospital day 3. Changepoint analysis, interrupted time series modeling, nonparametric comparisons, and multivariable linear regression assessed differences across periods. Regression models adjusted for community GI viral activity and calendar month. Rates were compared by unit and pathogen. Median HA-VGI rates declined significantly during Period 2 compared with Period 1 (0.93 vs. 5.14 per 10,000 patient days; p<0.001). Although rates increased in Period 3, they remained below Period 1. Adjusted regression demonstrated lower rates during Periods 2 and 3 than during Period 1 (β=-3.01 and -3.07, respectively; both p<0.001). Period 4 did not significantly differ from Period 1. Community GI viral activity was independently associated with HA-VGI rates (β=5.94; p=0.002). ICU rates were lower than non-ICU rates; norovirus predominated. Year-round sibling visitation with visitor limits was not associated with increased HA-VGI incidence compared to seasonal visitation. Mandatory masking was associated with lower HA-VGI rates independent of community viral activity and seasonality and may provide protection during increased GI viral circulation.

PMID 43039321
阅读全文 →
PubMedJournal of critical care2026-11-14

Prognostic value of the lactate-to-albumin ratio for mortality in patients with sepsis: A systematic review and meta-analysis.

Murrieta Bruciaga Lorena María LM, Lim Anthony M AM, Castañeda Martínez Jesús Antonio JA, Cruz Castillo Yeison Y et al.

Sepsis remains a leading cause of morbidity and mortality worldwide. The lactate-to-albumin ratio (LAR) has emerged as a promising prognostic biomarker; however, its performance across different mortality outcomes has not been comprehensively evaluated. Following PRISMA guidelines, four databases were searched, and the protocol was preregistered on PROSPERO (CRD420261381173). Prognostic outcomes were pooled as hazard ratios (HRs) and odds ratios (ORs). Discriminative performance was assessed by pooling area under the receiver operating characteristic curve (AUC) values. Heterogeneity was assessed using I2 statistics. 23 studies involving 9838 patients were included. Elevated LAR was associated with increased ICU mortality (HR = 1.24; 95% CI: 1.02-1.51; p = 0.04; I2 = 0.02% and OR = 2.52; 95% CI: 1.10-5.76; p = 0.03; I2 = 76.08%) and overall mortality (OR = 2.25; 95% CI: 1.72-2.95; p < 0.01; I2 = 0%). Pooled AUCs were 0.76 (95% CI 0.66-0.83; p < 0.01; I2 = 90%) for 28-day mortality, 0.79 (95% CI 0.60-0.90; p = 0.01; I2 = 95.3%) for ICU mortality, and 0.82 (95% CI 0.59-0.94; p = 0.02; I2 = 95%) for in-hospital mortality. Elevated LAR is associated with increased mortality and demonstrated moderate-to-good discriminative performance across multiple mortality outcomes in sepsis. Given its simplicity, low cost, and widespread availability, LAR may serve as a useful adjunct for early risk stratification.

PMID 43025025
阅读全文 →
PubMedJournal of clinical medicine2026-11-14

Comparative Prognostic Performance of 18 Routine Laboratory-Derived Indices for In-Hospital Mortality in Patients with COVID-19.

Yıldırım Mehmet Serdar MS, Bingöl Ferhat F, Özçaylak Süleyman S, Demir Nizam N et al.

Background/Objectives: Numerous hematologic, inflammatory, biochemical, and nutritional indices have been proposed as prognostic markers in coronavirus disease 2019 (COVID-19), but direct comparison of a broad range of these indices within the same cohort remains limited. This study aimed to evaluate and compare the prognostic performance of multiple routinely available indices for in-hospital mortality. Methods: This retrospective observational cohort included 1952 adults hospitalized with COVID-19. Demographic, clinical, comorbidity, and laboratory data were obtained from medical records. Eighteen derived indices were evaluated, including NLR, PLR, SII, CAR, CLR, LAR, UAR, CPR, DAR, and PNI. Receiver operating characteristic analysis was performed to assess discrimination for in-hospital mortality, and optimal cut-offs were determined using the Youden index. Selected indices were further evaluated in separate multivariable logistic regression models adjusted for age, sex, diabetes mellitus, CAD/IHD, and eGFR. Results: In-hospital mortality occurred in 80 patients (4.1%). Non-survivors were older and had higher inflammatory and biochemical markers and lower lymphocyte counts and albumin levels. CAR and CLR showed the highest numerical AUCs for in-hospital mortality (0.870 for both), followed by PNI (0.857), CPR (0.852), DAR (0.829), UAR (0.823), LAR (0.815), and NLR (0.807). In separate multivariable models adjusted for age, sex, diabetes mellitus, CAD/IHD, and eGFR, ln(CLR), ln(CAR), ln(CPR), ln(LAR), ln(UAR), ln(NLR), ln(dNLR), and ln(DAR) remained independently associated with mortality (all p < 0.001). Among the adjusted models, the CLR model showed the highest explained variance (Nagelkerke R2 = 0.511) with good calibration (Hosmer-Lemeshow p = 0.997); ln(CLR) remained independently associated with mortality (aOR 3.590, 95% CI 2.517-5.120; p < 0.001). Conclusions: Several routinely available composite indices were associated with in-hospital mortality in COVID-19. Among the evaluated indices, CAR and CLR showed the highest individual discrimination, while the CLR-based adjusted model showed the most favorable model-fit profile among the multivariable models evaluated. Multiple selected indices remained independently associated with mortality after adjustment for clinical covariates. These findings suggest that such markers may have potential value as adjunctive tools for mortality risk stratification.

PMID 43030562
阅读全文 →
PubMedThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology2026-11-14

Comparative Evaluation of Albumin-Based Ratios for Predicting Intensive Care Unit Admission and Mortality in Acute Pancreatitis.

Yildiz Mehmet M, Tosun Mustafa M, Altınkaya Engin E, Ataseven Hilmi H

Early identification of patients at risk for severe acute pancreatitis (AP) remains challenging. The authors compared the performance of albumin-based ratios in predicting intensive care unit (ICU) admission and mortality among patients with AP. This retrospective cohort study included 499 patients with AP. The C-reactive protein (CRP)/albumin ratio (CAR), glucose/albumin ratio (GAR), lactate dehydrogenase/albumin ratio (LAR), and red cell distribution width/albumin ratio (RAR) were calculated at admission and during the early phase of hospitalization. The need for ICU admission was the primary outcome. Eleven patients (2.2%) required ICU admission, and 5 (1.0%) died. At admission, CAR was elevated in patients requiring ICU admission (14.27 vs. 3.31, P = .022). At 48 hours, CAR was significantly higher in patients requiring ICU admission (88.86 vs. 13.24, P < .001) and demonstrated high discriminative ability (area under the curve [AUC], 0.921; 95% CI, 0.85-0.98), comparable with that of CRP (AUC = 0.922, P = .964). GAR and RAR demonstrated more modest associations. Exploratory mortality analyses suggested that earlyphase CAR at 48 hours and admission RAR were higher among nonsurvivors. Early-phase (48 hours) CAR is a reliable predictor of ICU admission in patients with AP, with predictive performance comparable with that of CRP while incorporating albumin status. It may serve as a simple adjunctive tool for early risk stratification. Cite this article as: Yildiz M, Tosun M, Altınkaya E, Ataseven H. Comparative evaluation of albumin-based ratios for predicting intensive care unit admission and mortality in acute pancreatitis. Turk J Gastroenterol. 2026;37(11):1176-1183.

PMID 43026632
阅读全文 →
PubMedAnatomical record (Hoboken, N.J. : 2007)2026-11-13

Enamel thickness in the stem hylobatid Kapi ramnagarensis (Primates, Hylobatidae).

Ortiz Alejandra A, Gilbert Christopher C CC, Di Xinyue X, Pugh Kelsey D KD et al.

Enamel thickness has been extensively investigated in extant and fossil hominids, yet comparable data for hylobatids remain scarce. Existing studies are limited to Symphalangus syndactylus, Hylobates lar, and Hylobates muelleri and are based on relatively small samples. These studies have characterized enamel thickness as thin in Symphalangus and Hy. lar and intermediate-thin in Hy. muelleri. The polarity of these conditions within Hylobatidae also remains unresolved because stem representatives of the clade have only recently been discovered. Here, we used microcomputed tomography to examine lower third molar (M3) enamel thickness in the stem hylobatid Kapi ramnagarensis from the Miocene Lower Siwaliks locality of Ramnagar. We also provide new comparative data from 19 M3s of extant hylobatids representing all four living genera. Average (AET) and relative (RET) enamel thickness were quantified from two-dimensional virtual sections passing through the dentin horns of the two mesial cusps. The M3 of the single Kapi specimen exhibits enamel thickness values within the range observed in extant hylobatids, albeit near the lower end of that distribution, with RET most closely matching that of Hoolock leuconedys. Parsimony-based ancestral state reconstructions of M3 RET using gap-weighted coding hypothesize an intermediate-thin enamel condition at the base of Hominoidea. Within Hylobatidae, the ancestral state was likewise reconstructed as intermediate-thin enamel. Although RET provides valuable phylogenetic information, its interpretation remains challenging due to the limited data for early catarrhines and hominoids and the pervasive influence of homoplasy. Larger samples will help clarify patterns of enamel thickness variation within hylobatids and across Hominoidea.

PMID 43023608
阅读全文 →

注册免费账户还可查看另外 5368 篇文献

免费注册查看全部文献 →

了解更多pasireotide